BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30073092)

  • 1. Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review.
    Fernández Moro C; Bozóky B; Gerling M
    BMJ Open Gastroenterol; 2018; 5(1):e000217. PubMed ID: 30073092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
    Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
    BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
    Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
    Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.
    Nierop PM; Höppener DJ; Buisman FE; van der Stok EP; Galjart B; Balachandran VP; Jarnagin WR; Kingham TP; Shia J; Mauer M; Nordlinger B; Julié C; Groot Koerkamp B; Doukas M; Vermeulen PB; Grünhagen DJ; D'Angelica MI; Verhoef C
    J Pathol Clin Res; 2022 Jan; 8(1):48-64. PubMed ID: 34480530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.
    Bolhuis K; Kos M; van Oijen MGH; Swijnenburg RJ; Punt CJA
    Eur J Cancer; 2020 Dec; 141():225-238. PubMed ID: 33189037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
    Falcão D; Alexandrino H; Caetano Oliveira R; Martins J; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Cipriano MA; Castro E Sousa F
    Eur J Surg Oncol; 2018 Aug; 44(8):1212-1219. PubMed ID: 29691114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases.
    Buisman FE; van der Stok EP; Galjart B; Vermeulen PB; Balachandran VP; Coebergh van den Braak RRJ; Creasy JM; Höppener DJ; Jarnagin WR; Kingham TP; Nierop PMH; Sadot E; Shia J; Groot Koerkamp B; Grünhagen DJ; D'Angelica M; Verhoef C
    Clin Exp Metastasis; 2020 Oct; 37(5):593-605. PubMed ID: 32691187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological growth patterns and positive margins after resection of colorectal liver metastases.
    Nierop PMH; Höppener DJ; van der Stok EP; Galjart B; Buisman FE; Balachandran VP; Jarnagin WR; Kingham TP; Allen PJ; Shia J; Vermeulen PB; Groot Koerkamp B; Grünhagen DJ; Verhoef C; D'Angelica MI
    HPB (Oxford); 2020 Jun; 22(6):911-919. PubMed ID: 31735649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
    Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
    J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature.
    Kron P; Linecker M; Jones RP; Toogood GJ; Clavien PA; Lodge JPA
    Front Oncol; 2019; 9():1052. PubMed ID: 31750233
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis.
    Gau L; Ribeiro M; Pereira B; Poirot K; Dupré A; Pezet D; Gagnière J
    Eur J Surg Oncol; 2021 Nov; 47(11):2722-2733. PubMed ID: 34099355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hepatic steatosis on outcomes of colorectal cancer patients with liver metastases: A systematic review and meta-analysis.
    Yang S; Peng R; Zhou L
    Front Med (Lausanne); 2022; 9():938718. PubMed ID: 36160137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment.
    Lemke J; Cammerer G; Ganser J; Scheele J; Xu P; Sander S; Henne-Bruns D; Kornmann M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e183-e192. PubMed ID: 27269232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study.
    Höppener DJ; Galjart B; Nierop PMH; Buisman FE; van der Stok EP; Coebergh van den Braak RRJ; van Amerongen MJ; Balachandran VP; Jarnagin WR; Kingham TP; Doukas M; Shia J; Nagtegaal ID; Vermeulen PB; Koerkamp BG; Grünhagen DJ; de Wilt JHW; D'Angelica MI; Verhoef C
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34056541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological growth patterns of colorectal cancer liver metastases: a strong prognostic marker associated with invasive patterns of the primary tumor and p53 alteration.
    Abe H; Yasunaga Y; Yamazawa S; Nakai Y; Gonoi W; Nishioka Y; Murono K; Sasaki K; Arita J; Kawai K; Nozawa H; Hasegawa K; Ishihara S; Ushiku T
    Hum Pathol; 2022 May; 123():74-83. PubMed ID: 35247436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrospective cohort study of statin therapy effect on resected colorectal liver metastases.
    Alabraba E; Ibrahim H; Olaru A; Cameron I; Gomez D; Group NHS
    World J Gastrointest Surg; 2020 Feb; 12(2):34-44. PubMed ID: 32128027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection.
    Sanyal S; Alabraba E; Ibrahim H; Olaru A; Cameron I; Gomez D
    J Gastrointest Cancer; 2021 Mar; 52(1):106-112. PubMed ID: 31853827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat hepatectomy justified in patients with early recurrence of colorectal cancer liver metastases: A systematic review and meta-analysis.
    Hellingman T; de Swart ME; Heymans MW; Jansma EP; van der Vliet HJ; Kazemier G
    Cancer Epidemiol; 2021 Oct; 74():101977. PubMed ID: 34303642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.